Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 14, 2017; 23(26): 4675-4688
Published online Jul 14, 2017. doi: 10.3748/wjg.v23.i26.4675
Published online Jul 14, 2017. doi: 10.3748/wjg.v23.i26.4675
Figure 1 Colorectal cancer consensus gene expression-based subtypes[83].
CIMP: CpG island methylator phenotype; MSI: Microsatellite instability; SCNA: Somatic copy number alterations; BRAF: B-Raf proto-oncogene, serine/threonine kinase; KRAS: Kirsten rat sarcoma viral oncogene; TGF: Transforming growth factor; APC: Adenomatous polyposis coli.
- Citation: Martini G, Troiani T, Cardone C, Vitiello P, Sforza V, Ciardiello D, Napolitano S, Della Corte CM, Morgillo F, Raucci A, Cuomo A, Selvaggi F, Ciardiello F, Martinelli E. Present and future of metastatic colorectal cancer treatment: A review of new candidate targets. World J Gastroenterol 2017; 23(26): 4675-4688
- URL: https://www.wjgnet.com/1007-9327/full/v23/i26/4675.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i26.4675